Cahill Represents Lead Arrangers in $950 Million Credit Facilities to support Altaris Capital Partners’ Acquisition of Padagis LLC
Date: 07/06/21
Cahill represented the lead arrangers in connection with a $850,000,000 term B credit facility and a $100,000,000 revolving credit facility to support Altaris Capital Partners’ bid to acquire Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo Company plc. Padagis is a leader in the generic prescription pharmaceutical industry and has more than 1,300 employees across six locations in the United States and Israel.